Gait in Young Children With NF1

Starting soon

Conditions studied: Neurofibromatosis Type 1

In brief

The objective of this study is to develop office-based tools to quantify gait in young children with NF1 that reflect overall gross motor impairment and predict future gross motor difficulties.

Key facts

Study ID

NCT07564622

Run by

NYU Langone Health

People needed

56

Starts

2026-08-01

Expected to finish

2031-01-31

Last updated by the study team

2026-05-08

Who can join

Age: any, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children who are independently ambulatory who meet revised diagnostic criteria for NF1
• Children less than or equal to 71 months of age
• Parent/Legal Guardian willing and able to provide parental consent.

You may not qualify if…

• Age ≥ 6 years old, inability to walk 10 meters independently, non-NF1 medical illness that alters their physical or neurological abilities that could significantly impact their performance.
• Parent/Legal Guardian not willing and able to provide parental consent

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.